How is the treatment for nasopharyngeal carcinoma stage 4a?

Nasopharyngeal carcinoma is a common malignant cancer with a relatively high incidence rate. The treatment methods for late-stage nasopharyngeal carcinoma have been significantly improved compared with the past. In fact, the treatment of late-stage nasopharyngeal carcinoma is related to the patient's physical condition, and there is no guarantee that the late-stage treatment of nasopharyngeal carcinoma will be cured. As far as the current situation is concerned, it is generally believed in the clinic that the main treatment methods for late-stage nasopharyngeal carcinoma include traditional Chinese medicine treatment, radiotherapy and chemotherapy, biological DC-CIK immunotherapy, etc. However, the specific treatment method to be adopted should be based on the patient's physical condition and condition to choose a scientific and reasonable treatment plan.

Radiotherapy and chemotherapy for nasopharyngeal carcinoma

In the treatment of advanced nasopharyngeal carcinoma in Shanghai, radiotherapy and chemotherapy can kill tumor cells locally or systemically, and the effect is fast, but they cannot eradicate tumor cells, are prone to metastasis, recurrence, and have great systemic toxic side effects. They are very likely to cause nausea, vomiting, loss of appetite, hair loss and other symptoms, aggravating the patient's condition and causing damage to the body's immune function. Traditional Chinese medicine treatment is slow to take effect and cannot achieve ideal therapeutic effects in a short period of time.

Biological DC-CIK Immunotherapy for Nasopharyngeal Carcinoma

Biological DC-CIK immunotherapy is the latest tumor treatment technology that is superior to surgery, radiotherapy and chemotherapy. It is a treatment method that uses biotechnology to cultivate autologous immune cells that can kill tumors in a high-standard laboratory, and then infuse them into the body to directly kill cancer cells. Different from traditional treatment methods, biological DC-CIK immunotherapy mainly mobilizes the body's natural anti-cancer ability and restores the balance of the body's internal environment. Clinically, biological DC-CIK immunotherapy is often combined with radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. Biological DC-CIK immunotherapy can accurately kill residual cancer cells, improve the effect of radiotherapy and chemotherapy, enhance the patient's immune ability, and better prevent metastasis and recurrence. It has the effect of reducing the toxicity and increasing the efficacy of radiotherapy and chemotherapy, which is conducive to the smooth progress of radiotherapy and chemotherapy.